SGC gets FDA IND approval for gummy-based allergy medication
Seattle Gummy Company claimed that the recent IND approval marks the first FDA approval for a gummy-based medication
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Oct 20
Seattle Gummy Company claimed that the recent IND approval marks the first FDA approval for a gummy-based medication
Healthcare reporter Jamie Bell takes a look at seven nutraceutical companies innovating to produce functional foods, health supplements…
Melvine D'Silva, Soriyano D'Souza and Ramakant Lal were all directors at Vivid Lifestyle before the company was ordered…
Cost pressures on drug development are driving the search for savings and efficiencies during clinical trials. ICON knows…
Serialisation is an effective method of certifying pharmaceutical shipments, but it remains vulnerable to abuse. World Pharmaceutical Frontiers…
The viability of a clinical trial result is dependent on the integrity of the data acquired. Clinical Trials…
26 Sep 16
As global manufacturing regulations tighten to weed out counterfeit drugs from supply chains, suppliers have to come to…
18 Apr 16
Compliance requirements vary from region to region. Whether industry players are dealing with one or many regulatory mandates,…
21 Mar 16
Brand protection through authentication and serialization.
27 Jan 16
Cloud-based systems are reducing clinical trial costs by maximising data entry and workflow efficiencies. Zaher el-Assi, president of…